Boston Angel Investors →
XSITE 2013 →
Partner, Avalon Ventures
President and CEO, Millennium: The Takeda Oncology Company
General Partner, Alloy Ventures
President & CEO, Texas Biomedical Research Institute
Chief of Genetics, UC San Diego School of Medicine
President, Rockefeller University
General Partner, Flybridge Capital Partners
Ascent Therapeutics, based in Cambridge, MA, is developing a new class of drugs to target cell surface receptors involved in many diseases.
San Francisco · 6/3/13
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.
© 2007-2013, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.